Navigation Links
Researchers make case for standardized analysis of cardiac imaging
Date:3/13/2008

For accuracy's sake, medical professionals should use the same software for comparing and analyzing diagnostic heart images taken from different time periods and laboratories, a team of researchers has concluded.

The collaborative study, published in the January-February issue of the Journal of Nuclear Cardiology, involved physicians and researchers at Sacred Heart Medical Center in Eugene, the University of Oregon and Cedars-Sinai Medical Center in Los Angeles. The study, which involved images done on 328 heart patients at Sacred Heart, is part of an effort to standardize cardiac-image analyses to improve both diagnostics and patient care.

A lack of important consistency is evident from analyses now done with three widely used software packages, said Dr. Mathews Fish, medical director of nuclear cardiology at the Oregon Heart & Vascular Institute at Sacred Heart. Inconsistencies can occur, for example, he said, when comparing images done on over time or when results on a patient come from different labs.

Fish is part of a collaborative research project with Cedars-Sinai that includes a recently awarded grant from the National Institutes of Health (NIH) for the development of an automated high-performance system for analyzing cardiac SPECT (three dimensional) imaging. SPECT stands for single photon emission computed tomography, which uses gamma rays to create pictures of organs and their structures.

The recently published study is believed to be the first head-to-head comparison of the commercially available software used in such cardiac-related diagnostics.

Cardiac SPECT is performed in conjunction with stress testing to compare blood flow to the heart muscle when patients are at rest or stressed. The images are analyzed using computer software. The new study found significant differences in diagnostic performance and quantification of abnormalities in the state-of-the-art software packages being used for cardiac SPECT imaging.

Because of its high diagnostic accuracy in determining the presence of significant coronary artery disease and its ability to determine the risk of a heart attack, cardiac SPECT imaging has become a useful tool in the care of patients with suspected heart disease. Important management and treatment decisions are based not only on whether the test is abnormal, but also the degree of the abnormality, which is best determined by computer software.

The database used in the study to compare the various results was created and maintained by Santiago Lorenzo of Argentina, a doctoral student in the University of Oregons department of human physiology. Lorenzo adapted the results into Microsoft Access. "It was very useful to use since I had to constantly analyze the data in many different ways," he said. "Having the data organized made my job much easier."

Lorenzo's participation in the study was done as part of collaboration between the hospital and the UO's human physiology department.

"This study shows the tangible benefits of the Oregon Heart & Vascular Institutes research partnership with the University of Oregon," Fish said. "Such research performed locally in our own institutions greatly enhances the quality of medical outcomes and supports the use of the most appropriate and effective technology for the care of patients."


'/>"/>

Contact: Jim Barlow
jebarlow@uoregon.edu
541-346-3481
University of Oregon
Source:Eurekalert

Related medicine news :

1. Researchers find cause of severe allergic reaction to cancer drug
2. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
3. USC researchers find benefit for lymphoma patients in combined PET-CT scanning
4. Researchers ID behavioral risk factors for head and neck cancers
5. Red-light cameras increase crashes, researchers find
6. Leading researchers honored for progress in cancer prevention, detection and treatment
7. University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein
8. UCF researchers discover a new protein family implicated in inflammatory diseases
9. Size does matter: Researchers adapt drug dosing to body size
10. Burroughs Wellcome Fund grants $9.75 million towards translational researchers
11. Researchers Design Promising Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: